A single whole blood donation from a large-breed dog can be separated into three distinct blood products: packed red blood cells, fresh frozen plasma, and cryoprecipitate, each with different storage requirements and clinical indications. This component therapy approach means one donor can help up to three patients. Use the Blood Volume Estimates tool to ensure safe donation volumes and the Blood Transfusion Calculator for recipient dosing.
Selecting appropriate blood donors is the foundation of a safe and effective blood banking program. Ideal canine blood donors meet the following criteria:
- Weight: Greater than 25 kg (55 lbs) to safely donate a standard 450 mL unit
- Age: Between 1 and 8 years old
- Health status: Healthy on physical examination, no history of chronic illness
- Blood type: DEA 1.1 negative is strongly preferred as a "universal donor" type, though DEA 1.1 positive dogs can donate to DEA 1.1 positive recipients
- Vaccination: Current on core vaccines (DAPP, rabies)
- Parasite prevention: Current on heartworm prevention with negative heartworm test
- Temperament: Calm, tolerant of restraint and venipuncture
- No prior transfusion: Dogs that have received transfusions may have developed alloantibodies
- Not pregnant or recently pregnant
Donors can donate every 3-4 weeks, with a maximum of approximately 12 donations per year. A PCV should be checked before each donation to confirm it is >40%.
Every potential donor should undergo comprehensive screening before entering the program, and periodic rescreening should occur annually or semi-annually.
Initial screening: Complete blood count (CBC), serum chemistry panel, urinalysis, blood typing (DEA 1.1 at minimum, extended typing preferred), heartworm antigen test, and infectious disease screening. Infectious disease testing should include Babesia canis, Ehrlichia canis, Anaplasma phagocytophilum, Leishmania infantum (in endemic areas), Brucella canis, and Mycoplasma haemocanis via PCR.
Pre-donation check: At each donation, measure PCV (must be >40%), total protein (must be >6.0 g/dL), and perform a brief physical examination. A health history questionnaire should confirm no recent illness, travel to endemic disease areas, or medication administration.
Warning: Infectious disease screening is critical. A donor with subclinical Babesia or Mycoplasma infection can transmit these pathogens to immunocompromised recipients with devastating consequences. PCR testing is more sensitive than serology for detecting carrier states.
Blood collection should be performed using aseptic technique by trained personnel. The standard procedure involves:
Site preparation: The jugular vein is the preferred collection site due to its large caliber and high flow rate. Clip and surgically prep a 5 cm × 5 cm area over the jugular groove. The donor is typically positioned in lateral or sternal recumbency. Light sedation (butorphanol 0.2 mg/kg IV) may be used for anxious donors but is often unnecessary in well-conditioned donors.
Collection: Using a commercial blood collection set with a 16-gauge needle and a 450 mL collection bag containing CPDA-1 anticoagulant (63 mL per 450 mL bag), insert the needle into the jugular vein. Blood should flow freely by gravity. Gently rock the bag periodically during collection to mix the blood with anticoagulant. Collection of 450 mL typically takes 5-10 minutes.
Post-donation care: Apply pressure to the venipuncture site for 3-5 minutes. Offer the donor water and a high-value treat. Monitor for 15-30 minutes before discharge. Some programs administer SC fluids (10-20 mL/kg) to support volume recovery, though healthy dogs compensate rapidly without supplementation.
Whole blood can be separated into individual components through centrifugation, allowing targeted therapy and efficient use of donated blood.
| Component | Preparation | Storage | Shelf Life | Primary Indications |
|---|---|---|---|---|
| pRBC | Centrifuge whole blood; remove plasma | 1-6°C refrigerated | 35 days (CPDA-1) | Anemia without coagulopathy |
| FFP | Separate plasma within 8 hr; freeze at -18°C | -18°C or colder | 1 year | Coagulopathy (rodenticide, DIC), hypoalbuminemia |
| Frozen Plasma (FP) | FFP stored >1 year, or plasma separated >8 hr | -18°C or colder | 5 years | Albumin replacement (coagulation factors degraded) |
| Cryoprecipitate | Thaw FFP at 1-6°C; recover precipitate | -18°C or colder | 1 year | von Willebrand disease, hemophilia A, fibrinogen deficiency |
| Platelet-Rich Plasma | Light centrifugation of whole blood | 20-24°C with agitation | 5 days | Thrombocytopenia (limited use in veterinary) |
Packed Red Blood Cells (pRBC): Indicated for patients who need oxygen-carrying capacity without volume expansion or coagulation factors. Common scenarios include immune-mediated hemolytic anemia (IMHA), chronic blood loss anemia (GI hemorrhage, iron deficiency), and post-surgical anemia. Typical dose: 10-15 mL/kg, expected to raise PCV by 5-10%.
Fresh Frozen Plasma (FFP): Contains all coagulation factors, albumin, antithrombin, and immunoglobulins. Indicated for anticoagulant rodenticide toxicity, DIC, liver failure with coagulopathy, and as a source of antithrombin in protein-losing conditions. Typical dose: 10-20 mL/kg for coagulopathy correction.
Cryoprecipitate: Concentrated source of fibrinogen, von Willebrand factor (vWF), Factor VIII, Factor XIII, and fibronectin. Specifically indicated for von Willebrand disease (especially before surgery), hemophilia A, and hypofibrinogenemia. Advantage over FFP is smaller volume needed. Typical dose: 1 unit per 10 kg body weight.
The Internal Medicine Specialist can help determine the optimal blood product for complex cases involving multiple concurrent coagulopathies.
Whole blood transfusion remains appropriate when component separation is not available or when the patient needs both red cells and plasma components simultaneously (e.g., massive hemorrhage with coagulopathy). Use the Blood Transfusion Calculator for precise volume calculations.
Dogs have at least 12 blood group systems, with DEA (Dog Erythrocyte Antigen) 1.1 being the most clinically significant. Unlike cats, dogs do not have clinically significant naturally occurring alloantibodies against DEA 1.1. This means a first transfusion with mismatched blood is usually well tolerated, but subsequent mismatched transfusions can trigger severe hemolytic reactions.
DEA 1.1 negative dogs are preferred as universal donors because their red cells will not be destroyed by anti-DEA 1.1 antibodies in any recipient. DEA 1.1 positive dogs can only safely donate to DEA 1.1 positive recipients. Crossmatching is recommended for all dogs that have been previously transfused (beyond 4 days prior) or have an unknown transfusion history.
- Ideal canine donors: >25 kg, 1-8 years, healthy, DEA 1.1 negative, current on vaccines and heartworm prevention.
- Standard donation is 450 mL from the jugular vein using CPDA-1 anticoagulant; donors can give every 3-4 weeks.
- Component separation produces pRBC (35-day shelf life), FFP (1 year frozen), and cryoprecipitate (1 year frozen).
- Choose the component that matches the clinical need: pRBC for anemia, FFP for coagulopathy, cryo for vWD.
- Comprehensive infectious disease screening (PCR) of all donors is essential to prevent pathogen transmission.